Kevin Quon
Insider ownership, small-cap, long-term horizon, dividend investing

Pacific Biosciences Gains Traction Even As Impatience Grows

Pacific Biosciences of California, Inc. (PACB) is the developer of the PacBio RS II, a next-generation sequencing system expanding the field of science. The company develops, manufactures, and markets the high-end sequencing platform. This places the company in the same industry as more recognizable names such as Illumina (ILMN) and Thermo Fisher (formerly Life Technologies Corporation). The system utilizes Single Molecule, Real-Time DNA sequencing technology which provides the highest consensus accuracy and longest read lengths in the gene-sequencing industry.

The company remains a lesser known name despite its significant advances in technology. Initially plagued by high error run rates, the original PacBio system was largely dismissed by the industry early on. Yet critical software patches...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details